Subtypes of autism by cluster analysis based on structural MRI data
Language English Country Germany Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Autistic Disorder diagnosis MeSH
- Child MeSH
- Humans MeSH
- Magnetic Resonance Imaging * MeSH
- Brain abnormalities MeSH
- Cluster Analysis MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The aim of our study was to subcategorize Autistic Spectrum Disorders (ASD) using a multidisciplinary approach. Sixty four autistic patients (mean age 9.4+/-5.6 years) were entered into a cluster analysis. The clustering analysis was based on MRI data. The clusters obtained did not differ significantly in the overall severity of autistic symptomatology as measured by the total score on the Childhood Autism Rating Scale (CARS). The clusters could be characterized as showing significant differences: Cluster 1: showed the largest sizes of the genu and splenium of the corpus callosum (CC), the lowest pregnancy order and the lowest frequency of facial dysmorphic features. Cluster 2: showed the largest sizes of the amygdala and hippocampus (HPC), the least abnormal visual response on the CARS, the lowest frequency of epilepsy and the least frequent abnormal psychomotor development during the first year of life. Cluster 3: showed the largest sizes of the caput of the nucleus caudatus (NC), the smallest sizes of the HPC and facial dysmorphic features were always present. Cluster 4: showed the smallest sizes of the genu and splenium of the CC, as well as the amygdala, and caput of the NC, the most abnormal visual response on the CARS, the highest frequency of epilepsy, the highest pregnancy order, abnormal psychomotor development during the first year of life was always present and facial dysmorphic features were always present. This multidisciplinary approach seems to be a promising method for subtyping autism.
See more in PubMed
J Am Acad Child Adolesc Psychiatry. 2000 Jul;39(7):815-28 PubMed
J Autism Dev Disord. 1995 Dec;25(6):561-78 PubMed
Am J Psychiatry. 1997 Aug;154(8):1051-6 PubMed
J Autism Dev Disord. 1994 Feb;24(1):3-22 PubMed
J Autism Dev Disord. 1979 Mar;9(1):11-29 PubMed
J Autism Dev Disord. 1980 Mar;10(1):91-103 PubMed
J Child Psychol Psychiatry. 2000 Sep;41(6):679-94 PubMed
Eur Child Adolesc Psychiatry. 1995 Apr;4(2):123-35 PubMed
Eur Child Adolesc Psychiatry. 1995 Oct;4(4):249-58 PubMed
Neurology. 2000 Oct 10;55(7):1033-6 PubMed
Prog Neuropsychopharmacol Biol Psychiatry. 1999 May;23(4):613-24 PubMed
Eur Child Adolesc Psychiatry. 2004 Apr;13(2):115-22 PubMed
Neuroreport. 1999 Jun 3;10(8):1647-51 PubMed
J Autism Dev Disord. 1993 Jun;23(2):229-41 PubMed
J Autism Dev Disord. 1994 Oct;24(5):659-85 PubMed
Biol Psychiatry. 1997 Dec 15;42(12):1148-56 PubMed
J Neuropsychiatry Clin Neurosci. 1999 Fall;11(4):470-4 PubMed
Neurology. 1999 Dec 10;53(9):2145-50 PubMed
J Am Acad Child Adolesc Psychiatry. 1989 Jan;28(1):82-6 PubMed
Brain Dev. 2000 Mar;22(2):88-92 PubMed
J Child Psychol Psychiatry. 1975 Oct;16(4):321-30 PubMed
J Autism Dev Disord. 1986 Sep;16(3):275-93 PubMed
J Autism Dev Disord. 1989 Mar;19(1):109-17 PubMed
J Autism Dev Disord. 2001 Aug;31(4):411-22 PubMed
J Autism Dev Disord. 1994 Feb;24(1):23-37 PubMed
J Autism Dev Disord. 1988 Dec;18(4):475-92 PubMed
Arch Gen Psychiatry. 2000 Apr;57(4):331-40 PubMed
J Autism Dev Disord. 1996 Jun;26(3):321-35 PubMed
J Am Acad Child Adolesc Psychiatry. 2000 Mar;39(3):346-52 PubMed
